November 28, 2025

TOP NEWS

 

Ashoka Buildcon has received a Show Cause Notice from NHAI regarding the girder collapse incident on the Aroor–Thuravoor NH-66 elevated corridor project, which resulted in a fatality. NHAI has temporarily suspended the company from participating in ongoing and future bids for one month or until the expert committee completes its investigation. The notice was received on November 26, 2025. Negative

 

TCS: The IT company announced a five-year deal with SAP to drive enterprise-wide Cloud and Generative AI transformation. Under the partnership, the company will streamline SAP’s IT landscape, enable smoother operations, and strengthen AI-led capabilities—aiming for faster development cycles, lower costs, and better alignment between IT and business goals.

 

Wipro: The company announced a multi-year deal with Odido Netherlands B.V. to modernise its IT landscape and enhance customer experience across enterprise and consumer segments. The partnership will use AI-led solutions to boost engagement, productivity and operational efficiency. It also adopts a self-funded model, where productivity savings are reinvested to support ongoing digital innovation.

 

Lodha Developers: The Supreme Court has ordered the refund of Rs.520.8 crore (plus interest) to Lodha Developers and confirmed Lodha as the legitimate successful Resolution Applicant of V Hotels. The ED will have no lien on VHL’s properties. Positive

 

Eureka Forbes: The company targets Financial Year 2030 revenue of Rs 5,400–5,600 crore and Ebitda of Rs 800–850 crore, aiming for over 2x revenue and 3x Ebitda growth, with its robotics business projected to scale 25x by Financial Year 2030. Positive

 

Zydus Life: The company has received tentative approval from the United States Food and Drug Administration (USFDA) for Empagliflozin and Linagliptin tablets, 10 mg/5 mg and 25 mg/5 mg.These tablets, used to improve glycaemic control in adults with type 2 diabetes mellitus, recorded annual sales of $215.8 million in the United States (as per IQVIA MAT September 2025). Also,  the company has signed a memorandum of understanding to export medicines to Afghanistan. Over time, the company will relocate its representative office to Afghanistan and begin domestic drug production.

 

Refex industries: The company receives a Rs 100 crore order from a large business conglomerate for the supply of bottom ash and related services. Positive

 

Adani Enterprises: The company’s arms, Adani Defence Systems and Horizon Aero Solutions, sign a pact to acquire a 72.8% stake in Flight Simulation Technique Centre for an enterprise value of Rs 820 crore. Positive

 

GAIL: long-awaited transmission tariff revision orders were issued by the PNGRB. The new transmission tariff levy will be Rs 65.7 per Million Metric British Thermal Unit (MMBtu), compared to the current Rs 58.6 per MMBtu. This implies a 12% (Street was expecting a 20% increase) increase in tariffs from the current levels. However the tariff is lower than Rs 78 / MMBTU expected by the company. Negative read through for GAIL.

 

Bandhan Bank: The Board has approved the proposal to sell identified non-performing assets (NPA) amounting to Rs 3,212.17 crore and written-off portfolios worth Rs 3,719.14 crore through a bidding process involving Asset Reconstruction Companies (ARC) or permitted transferees. The loan portfolios belong to the emerging entrepreneurs business, including group loans, small business and agri loans, and the aspiring business group of the bank. Sentimentally positive

 

 

INVESTMENT CALL

 

Stock update: Jubilant Foodworks – Eyeing volume and store-driven growth

Reco: Buy                  Reco. Price: Rs. 606                 Price Target: Rs. 750

  • Jubilant Foodworks (JFL) continues to focus on free delivery, loyalty programs, product innovation, value offerings and faster delivery to drive growth. It expects Domino’s India to grow ~15% y-o-y in FY26, led by 5-7% LFL growth and 7-10% from store additions.
  • Management reiterated its guidance of a 200-bps rise in EBITDA margins by FY28 (over FY24 base) led by better gross margins (procurement/mix), operating leverage (rentals/other lines), calibrated pricing, and productivity (supply chain, G&A).
  • JFL plans to add ~1,000 stores across brands over three years, targeting higher openings in Q1 and Q2, ahead of the festive period.
  • Stock trades at 24x/20x/17x its FY26E/FY27E/FY28E consolidated EV/EBIDTA, respectively. We maintain a Buy rating with an unchanged PT of Rs. 750.

 

Valuation (Consolidated)                                                   Rs. crore

Particulars

FY24

FY25

FY26E

FY27E

FY28E

Revenue

5,655

8,142

9,417

10,782

12,222

EBITDA Margin (%)

20.2

19.3

20.0

20.5

20.9

Adjusted PAT

258

238

355

556

746

Adjusted EPS (Rs.)

4.2

3.5

5.4

8.4

11.3

EV/EBITDA (x)

38.7

28.3

23.3

19.7

16.6

RoNW (%)

12.3

11.1

15.9

21.2

23.4

RoCE (%)

10.2

12.2

15.0

19.2

23.6

 

 

OTHER NEWS

 

Global Health : Medanta has expanded its NCR footprint with a new 550-bed super speciality hospital in Noida. Located in Sector 50 with metro connectivity, the facility houses 200+ doctors and 25+ super specialities, along with advanced ICUs and operating theatres.

 

RVNL : The company has received a Rs. 9.64 crore order from East Coast Railway to supply, install, test, and commission IP-based video surveillance systems for rolling stock, to be completed within 180 days.

 

Mahindra Lifespace : The company has received a Statement of Claim of Rs. 32.96 crore from Parekh & Brothers in an ongoing arbitration, which includes Rs. 22.22 crore for alleged delay compensation. The company will contest the claim and file counterclaims, and does not expect any material financial impact since it believes it has a strong case.

 

Bajaj Healthcare: The company has appointed industry veteran Shreekumar Shankarnarayan Nair as its Chief Operating Officer, effective immediately. Approved via a board circular on November 27, his appointment brings over 40 years of pharma leadership experience, including senior roles at Alembic and Glenmark. Positive